{
  "id": 8567,
  "url": "https://doi.org/10.1038/s41467-019-11306-6",
  "title": "FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science",
  "summary": "FDA proactively invests in tools to support innovation of emerging technologies, such as infectious disease next generation sequencing (ID-NGS). Here, we introduce FDA-ARGOS quality-controlled reference genomes as a public database for diagnostic purposes and demonstrate its utility on the example of two use cases. We provide quality control metrics for the FDA-ARGOS genomic database resource and outline the need for genome quality gap filling in the public domain. In the first use case, we show",
  "authors": "Heike Sichtig, Timothy D. Minogue, Yi Yan, Christopher P. Stefan, Adrienne T. Hall, Luke J. Tallon",
  "category": "research",
  "topics": "regulation,healthcare,finance-investment,biotech",
  "orgs": null,
  "regions": null,
  "published_at": "2019-07-25T00:00:00.000Z",
  "fetched_at": "2026-07-14T16:33:39.873Z",
  "source_slug": "openalex",
  "source_name": "OpenAlex",
  "source_homepage": "https://openalex.org",
  "ethics_ai_record_url": "https://ethics.ai/record/8567",
  "original_url": "https://doi.org/10.1038/s41467-019-11306-6",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}